Epstein Secrets

list. Maybe along the way also help some of these kids with genetic disorders that we haven't been able to molecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe EFTA00676660

2013 16:16:57 +0000 from Joe Thakuria...a follow up to his last email... It's exciting since with the exception of the clinical whole genome (that Illumina has offered for years but at a very low volume due to cost and very limited clinical indication (for now)), the other stuff (including the clinical

list. Maybe along the way also help some of these kids with genetic disorders that we haven't been able to molecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe On Tue, Dec 3, 2013 at 4:36 PM, Lesley Groff > wrote: thanks so much for this Joe...we will await an invoice...a

Jeffrey Epstein-Coordinate Payment Date: Tue, 03 Dec 2013 21:48:33 +0000 It's exciting since with the exception of the clinical whole genome (that Illumina has offered for years but at a very low volume due to cost and very limited clinical indication (for now)), the other stuff (including the clinical

ist. Maybe along the way also help some of these kids with genetic disorders that we haven't been able to molecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe EFTA00378431

2013 16:16:57 +0000 from Joe Thakuria...a follow up to his last email... It's exciting since with the exception of the clinical whole genome (that Illumina has offered for years but at a very low volume due to cost and very limited clinical indication (for now)), the other stuff (including the clinical

list. Maybe along the way also help some of these kids with genetic disorders that we haven't been able to molecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe On Tue, Dec 3, 2013 at 4:36 PM, Lesley Groff > wrote: thanks so much for this Joe...we will await an invoice...a

ith invoice... Lesley On Dec 3, 2013, at 4:48 PM, Joseph Thakuria wrote: It's exciting since with the exception of the clinical whole genome (that Illumina has offered for years but at a very low volume due to cost and very limited clinical indication (for now)), the other stuff (including the clinical

list. Maybe along the way also help some of these kids with genetic disorders that we haven't been able to molecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe The information contained in this communication is confidential, may be attorney-client privileged, may constitu

sley Groff > wrote: from Joe Thakuria...a follow up to his last email... It's exciting since with the exception of the clinical whole genome (that Illumina has offered for years but at a very low volume due to cost and very limited clinical indication (for now)), the other stuff (including the clinical

list. Maybe along the way also help some of =hese kids with genetic disorders that we haven't been able to =olecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe=?xml version=.0" encoding=TF-8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/P

bject: Joe Thakuria from Joe Thakuria...a follow up to his last email... It's exciting since with the exception of the clinical whole genome =that Illumina has offered for years but at a very low volume due to =ost and very limited clinical indication (for now)), the other stuff =including the clinical

list. Maybe along the way also help some of =hese kids with genetic disorders that we haven't been able to =olecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe=?xml version=.0" encoding=TF-8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/P

bject: Joe Thakuria from Joe Thakuria...a follow up to his last email... It's exciting since with the exception of the clinical whole genome =that Illumina has offered for years but at a very low volume due to =ost and very limited clinical indication (for now)), the other stuff =including the clinical

list. Maybe along the way also help some of =hese kids with genetic disorders that we haven't been able to =olecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe=?xml version=.0" encoding=TF-8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//EN" "http://www.apple.com/DTDs/P

bject: Joe Thakuria from Joe Thakuria...a follow up to his last email... It's exciting since with the exception of the clinical whole genome =that Illumina has offered for years but at a very low volume due to =ost and very limited clinical indication (for now)), the other stuff =including the clinical

ple, clinical sequencing could have areas of diminished or absent coverage in the genes examined for incidental findings that would be filled in by Sanger sequencing or other supplemen- tary approaches if the gene were being evaluated for a primary indication. In addition, although genome sequencing ca

R.L.N., K.E.O., and H.L.R. have grants related to genome sequencing. L.G.B. and H.L.R. ACMG POLICY STATEMENT receive in-kind research support from Illumina. J.S.B. and H.L.R. are uncompensated members of the advisory board for Complete Genomics. H.L.R. is a compensated member of the advisory boards fo